Medigene gets OK for first trial of T-cell receptor therapy – FierceBiotech
FierceBiotech |
Medigene gets OK for first trial of T–cell receptor therapy
FierceBiotech Medigene gets OK for first trial of T–cell receptor therapy. by Phil Taylor |. Feb 21, 2018 9:25am. Human T cell. Analysts say TCR may have advantages over other technologies like CAR-T. Share Facebook Twitter LinkedIn Email Print. Medigene has been … |
